To the Editor: Schauer et al. and Mingrone et al. report that bariatric surgery led to major improvements in metabolic control and remission of type 2 diabetes. According to the accompanying editorial by Zimmet and Alberti, 1 these two studies "are likely to have a major effect on future diabetes treatment." However, the beneficial role of a huge negative energy balance per se may have been neglected. In patients with type 2 diabetes, a very-low-calorie diet results in fast (within a few days), dramatic amelioration of metabolic control, with eventual reversal of the diabetic this week's letters 
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To the Editor: Schauer et al. report that "in obese patients with uncontrolled type 2 diabetes, 12 months of medical therapy plus bariatric surgery achieved glycemic control in significantly more patients than medical therapy alone." We would like to call attention to a contradiction between what is stated in the title -obese patients -and the eligibility criteria, a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 27 to 43. According to the Centers for Disease Control and Prevention, the definition of obesity should be restricted to persons with a BMI of 30 or higher. 1 This definition must be clarified, since bariatric surgery for nonobese patients with type 2 diabetes is still controversial. In addition, the authors reported that 51 of 150 patients had a BMI of less than 35 before treatment assignment. Can the authors present outcome data regarding the subgroup of patients with a BMI of less than 30 who underwent surgery? Dr. Schauer and Colleagues Reply: GletsuMiller and Ziegler rightly emphasize the importance of perioperative monitoring for micronutrient and macronutrient deficiencies related to bariatric surgery. We did reference our nutrition assessment protocol, and our study protocol (available with the full text of our article at NEJM.org) is compatible with accepted guidelines. 1,2 We add that clinicians should continuously counsel patients on the importance of compliance with vitamin and nutrient regimens that may avert such nutritional deficiencies.
Frontoni and colleagues suggest that a "huge negative energy balance" such as that which occurs with a very-low-calorie diet may be a primary mechanism that explains the rapid improvement in glycemic control after bariatric surgery. Further, they suggest that a very-low-calorie diet may be a therapeutic method for treating type 2 diabetes. We concur that a negative energy balance is probably one mechanism of surgical improvement and remission of type 2 diabetes; however, evidence suggests that bariatric surgery does have important weight-loss-independent effects that exceed the benefits of a very-low-calorie diet.
Laferrère et al. found that patients who underwent gastric bypass had superior glycemic control at 1 month after surgery as compared with patients who had equivalent weight loss induced by a very-low-calorie diet alone. 3 Furthermore, they found that an incretin effect not seen after a very-low-calorie diet possibly explained the differential benefit of surgery. We likewise found that gastric bypass, due to an incretin effect possibly driven by gut hormones such as glucagonlike peptide 1, gastrointestinal peptide, and peptide YY 3-36 , induced superior glycemic improvement as compared with operations such as banding and sleeve gastrectomy, which appear to elicit weight loss but no or only a modest incretin ef- The comment by Fornari and colleagues that some of the patients in our study were not obese is technically correct; three patients had a BMI of 27 to 29. Because there were too few nonobese patients for outcome analysis, we did not make any claims about the effect of surgery on nonobese patients. However, we do believe that strict thresholds of overweight (BMI, 25 to 29), obese (BMI, 30 to 34), and severely obese (BMI, ≥35) are biologically arbitrary and thus are not the best measures for guiding the use of surgery in patients with diabetes. Rather, the option of surgery for diabetes should currently be based on a lack of adequate control with appropriate medical management. 
Dr. Mingrone and Colleagues Reply: Frontoni and colleagues suggest that a low-calorie diet is a better treatment for obese patients with type 2 diabetes than surgery. The beneficial effects of starvation on diabetes were the basis for the "Allen diet," which was described by Frederick Madison Allen as a diabetes therapy in 1920. More recent investigations have shown that a 7-day period of a very-low-calorie diet can reduce hepatic glucose output and improve insulin sensitivity and secretion. 1 Hence, reduced caloric intake may contribute to early improvement of diabetes after bariatric surgery.
However, our patients generally consume a semiliquid diet of 1000 to 1200 kcal per day after bariatric surgery, a caloric intake that is almost twice as high as the 400 to 800 kcal per day in very-low-calorie diets. When comparing patients with similar caloric intake, a significant improvement of insulin resistance by the homeostasis model assessment of insulin resistance (HOMA-IR) is seen as early as 7 days after Roux-en-Y gastric bypass, but not after gastric banding or calorie restriction. 2 Furthermore, as early as 1 week after biliopancreatic diversion, insulin sensitivity measured with the use of the euglycemic-hyperinsulinemic clamp is almost doubled. 3 There is also evidence that bariatric surgery and dietary weight loss result in substantially different changes in gastrointestinal hormones involved in glucose homeostasis. 4 All together, these data support the view that mechanisms beyond pure energy restriction play a role, at least after gastrointestinal bypass procedures (such as Roux-en-Y gastric bypass and biliopancreatic diversion).
Finally, although in clinical investigations the effects of a very-low-calorie diet on glucose disposal in type 2 diabetes are clear and sound, the application of a very-low-calorie diet as a longterm treatment of diabetes in real clinical practice is very difficult, if not impossible. In fact, as Yki-Järvinen observed in a recent editorial in Diabetologia, "remission in a week may not be a cure for life." 5 Gletsu-Miller and Ziegler appropriately note that either restrictive or malabsorptive bariatric surgery can be associated with deficiency of vitamins and trace elements. In fact, the supplementation of both is part of the standard treatment in patients after bariatric surgery. In our series, we reported four cases of typical microcytic anemia in patients with low serum iron levels and a high iron-binding capacity, and these patients presented with a marked reticulocyte
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